Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00198172
Status:
TERMINATED
Last Update Posted:
2014-06-03
First Post:
2005-09-08
Brief Title:
Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors
Sponsor:
Indiana University School of Medicine
Organization:
Indiana University
Organization Data
Organization:
Indiana University
Class:
OTHER
Study ID:
0008-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Indiana University School of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Indiana University | OTHER |